SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies
S. M. Reincke, M. Yuan, H.-C. Kornau, V. M. Corman, S. van Hoof, E. Sanchez-Sendin, M. Ramberger, W. Yu, Y. Hua, H. Tien, M. L. Schmidt, T. Schwarz, L. M. Jeworowski, S. E. Brandl, H. Foverskov Rasmussen, , J. Kreye
SARS-CoV-2 Beta variant infection generates lineage-specific antibodies and cross-reactive antibodies with neutralizing activity against wild-type and other variants.
bioRxiv · Sep 30, 2021Immunology